
The Center of Research in Transplantation and Translational Immunology (CR2TI) gathers researchers and clinicians who develop projects aiming to improve knowledge, diagnosis and treatments in transplantation and immune-mediated inflammatory diseases.
Biomarkers/Epigenetics/Immunology/Infection/Intensive care
Global fellowships (return phase only)/European fellowships
Core facilities of the CR2TI provide state-of-the-art scientific-technological infrastructure for the development of the proposed projects:
The CR2TI is funded by recurring public funders, national or regional public agencies, and charitable foundations. Some of our current fundings are:
The CR2TI develops industrial partnership with the objective to accelerate the discovery and development of new therapies and diagnostic tools. Since 10 years, 9 patents have been generated, 1 CRO company (Atlangram) has been founded and a collaborative contract is in progress within the framework of the French PIA program (Amadeite and Immunotherapy for Respiratory Symbiosis “AIRS” – with Olgram company). The CR2TI is frequently supported by the SATT-OV, which mission is to accelerate the process of technology transfer from publicly funded research toward industry.
We have experience in hosting international researchers and providing mentoring on career development. At the CR2TI, international researchers will:
There are weekly scientific meetings.
Candidates will benefit from scientific collaborations with our international networks (HAP2 project, Euniwell University) to develop their own experimental or clinical studies. Candidates could take advantage of pre-existing initiatives in our institution outreach activities.
The welcome office and information desk for foreign researchers in Nantes provide all support to manage the fellowships.
Application in process